• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cdk10 在肝细胞癌中的临床和生物学意义。

Clinical and biological significance of Cdk10 in hepatocellular carcinoma.

机构信息

Department of Hepatopancreatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.

出版信息

Gene. 2012 Apr 25;498(1):68-74. doi: 10.1016/j.gene.2012.01.022. Epub 2012 Feb 1.

DOI:10.1016/j.gene.2012.01.022
PMID:22326270
Abstract

Cyclin-dependent kinase 10 (Cdk10) is a Cdc2-related kinase and plays an essential role in the progression from the G2 to M phase of the cell cycle. However, relative little is known about its expression pattern, clinical relevance, and biological function in hepatocellular carcinoma (HCC). In the present study, we investigated the mRNA and protein expression levels of Cdk10 in 127 pairs of HCC samples and adjacent nontumorous liver tissues and evaluated its clinical significance. Additionally, we assessed the effects of restoration of Cdk10 on cell proliferation and drug sensitivity in HCC cells. We showed that the Cdk10 mRNA and protein expression was markedly decreased in HCC samples compared to adjacent nontumorous liver tissues. Quantitative real-time polymerase chain reaction and immunohistochemical studies revealed that reduced Cdk10 expression was significantly associated with alpha-fetoprotein levels, tumor size, and tumor stage. Ectopic expression of Cdk10 reduced HCC cell proliferation, blocked the cell cycle at the G0-G1 phase, as well as inhibited cell migration and anchorage-independent growth. Additionally, Cdk10 overexpression enhanced the chemosensitivity of HCC cells to cisplatin and epidoxorubicin, two chemotherapeutic agents commonly used in HCC. These data collectively demonstrate that reduced Cdk10 expression is closely linked to HCC development and progression. Restoration of its expression may have therapeutic benefits in treating this malignancy.

摘要

周期蛋白依赖性激酶 10(Cdk10)是一种与 Cdc2 相关的激酶,在细胞周期的 G2 期到 M 期进展中发挥着重要作用。然而,人们对其在肝细胞癌(HCC)中的表达模式、临床相关性和生物学功能知之甚少。在本研究中,我们研究了 127 对 HCC 样本及其相邻非肿瘤性肝组织中 Cdk10 的 mRNA 和蛋白表达水平,并评估了其临床意义。此外,我们评估了恢复 Cdk10 对 HCC 细胞增殖和药物敏感性的影响。我们发现,与相邻非肿瘤性肝组织相比,Cdk10 的 mRNA 和蛋白表达在 HCC 样本中明显降低。定量实时聚合酶链反应和免疫组织化学研究表明,Cdk10 表达降低与甲胎蛋白水平、肿瘤大小和肿瘤分期显著相关。Cdk10 的异位表达降低了 HCC 细胞的增殖能力,将细胞周期阻滞在 G0-G1 期,并抑制了细胞迁移和无锚定依赖性生长。此外,Cdk10 的过表达增强了 HCC 细胞对顺铂和表阿霉素这两种常用于 HCC 治疗的化疗药物的敏感性。这些数据表明,Cdk10 表达的降低与 HCC 的发生和发展密切相关。恢复其表达可能对治疗这种恶性肿瘤具有治疗益处。

相似文献

1
Clinical and biological significance of Cdk10 in hepatocellular carcinoma.Cdk10 在肝细胞癌中的临床和生物学意义。
Gene. 2012 Apr 25;498(1):68-74. doi: 10.1016/j.gene.2012.01.022. Epub 2012 Feb 1.
2
Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.在肝细胞癌中 S 期激酶相关蛋白 2 过表达的临床病理意义和功能。
Hum Pathol. 2012 Jul;43(7):1084-93. doi: 10.1016/j.humpath.2011.08.019. Epub 2011 Dec 26.
3
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.Mybl2 的表达受遗传控制,并有助于决定肝癌易感表型。
J Hepatol. 2011 Jul;55(1):111-9. doi: 10.1016/j.jhep.2010.10.031. Epub 2010 Dec 7.
4
FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo.FBI-1 促进肝癌细胞的增殖并增强其体内外对化疗的耐药性。
Cancer. 2012 Jan 1;118(1):134-46. doi: 10.1002/cncr.26251. Epub 2011 Jun 28.
5
MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.miRNA-122 通过调节多药耐药基因表达和诱导细胞周期阻滞使肝癌细胞对阿霉素和长春新碱敏感。
Cancer Lett. 2011 Nov 28;310(2):160-9. doi: 10.1016/j.canlet.2011.06.027. Epub 2011 Jul 2.
6
Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.原发性肝恶性肿瘤中醛酮还原酶 1-B10 基因的鉴定和表达分析。
J Hepatol. 2010 Feb;52(2):220-7. doi: 10.1016/j.jhep.2009.11.005. Epub 2009 Nov 25.
7
Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.肝细胞癌患者中 ATP 结合盒蛋白和酪氨酸激酶信号通路的基因表达相关性。
Anticancer Res. 2011 Nov;31(11):3883-90.
8
Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma.p57 的下调加速了肝癌的生长和侵袭。
Carcinogenesis. 2011 Dec;32(12):1897-904. doi: 10.1093/carcin/bgr220. Epub 2011 Oct 14.
9
Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.转移性肝细胞癌中异常的Polo样激酶1-Cdc25A信号通路
Clin Cancer Res. 2008 Nov 1;14(21):6813-20. doi: 10.1158/1078-0432.CCR-08-0626.
10
Expression of zinc finger 23 gene in human hepatocellular carcinoma.锌指蛋白 23 基因在人肝癌中的表达。
Anticancer Res. 2011 Oct;31(10):3595-9.

引用本文的文献

1
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.细胞周期蛋白依赖性蛋白激酶与生物学和疾病中的细胞周期调控
Signal Transduct Target Ther. 2025 Jan 13;10(1):11. doi: 10.1038/s41392-024-02080-z.
2
Downregulated CDK10 promotes cancer progression and radioresistance in lung cancer through activating the JNK/c-Jun signaling pathway.下调的 CDK10 通过激活 JNK/c-Jun 信号通路促进肺癌的癌症进展和放射抵抗。
BMB Rep. 2024 Jul;57(7):336-341. doi: 10.5483/BMBRep.2024-0036.
3
Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel.
基于 NGS 基因 panel 的多种癌症拷贝数变异景观及其临床应用。
Ann Med. 2023;55(2):2280708. doi: 10.1080/07853890.2023.2280708. Epub 2023 Nov 15.
4
Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase.Pin1 通过对肽-脯氨酰顺反异构酶的调节来调控真核蛋白激酶。
Adv Biol Regul. 2023 Jan;87:100938. doi: 10.1016/j.jbior.2022.100938. Epub 2022 Nov 30.
5
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.细胞周期蛋白与细胞周期蛋白依赖性激酶:从生物学特性到肿瘤发生及治疗机遇
J Cancer Res Clin Oncol. 2023 Apr;149(4):1585-1606. doi: 10.1007/s00432-022-04135-6. Epub 2022 Jul 4.
6
CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene.CDK10在胃肠道癌症中的双重作用:作为肿瘤抑制因子和癌基因
Front Oncol. 2021 Jun 30;11:655479. doi: 10.3389/fonc.2021.655479. eCollection 2021.
7
Integrative Analysis of Omics Data Reveals Regulatory Network of in Vitiligo Risk.组学数据的综合分析揭示白癜风风险的调控网络。
Front Genet. 2021 Feb 17;12:634553. doi: 10.3389/fgene.2021.634553. eCollection 2021.
8
CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets.肉瘤中的 CDK :疾病的介质和新兴的治疗靶点。
Int J Mol Sci. 2020 Apr 24;21(8):3018. doi: 10.3390/ijms21083018.
9
Development of a CDK10/CycM Kinase Screening Assay and Identification of First Small-Molecule Inhibitors.CDK10/CycM激酶筛选分析方法的开发及首个小分子抑制剂的鉴定
Front Chem. 2020 Feb 27;8:147. doi: 10.3389/fchem.2020.00147. eCollection 2020.
10
Association of Cyclin Dependent Kinase 10 and Transcription Factor 2 during Human Corneal Epithelial Wound Healing in vitro model.细胞周期蛋白依赖性激酶 10 和转录因子 2 在体外人角膜上皮伤口愈合模型中的相关性。
Sci Rep. 2019 Aug 14;9(1):11802. doi: 10.1038/s41598-019-48092-6.